Crossmark

Greenness assessment and stability-indicating HPTLC method for the concurrent analysis of dapagliflozin propanediol monohydrate and bisoprolol fumarate in a novel combined oral formulation

Crossref DOI link: https://doi.org/10.1007/s44371-025-00348-z

Published Online: 2025-11-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ninama, Heena

Koradia, Shaileshkumar K.
License Information

Text and Data Mining valid from 2025-11-04

Version of Record valid from 2025-11-04
More Information

Article History

Received: 13 August 2025

Accepted: 27 October 2025

First Online: 4 November 2025

Declarations

:

: Not applicable (This study did not involve human participants or live vertebrates; No human participants were involved in this research).

: The authors declare no competing interests.

Document is current

Any future updates will be listed below